Assistant Professor

Education and Training

Fellowship, 06/2018 Pediatric Infectious Disease, Boston Children's Hospital
Certificate, 05/2018 Advanced Training in Clinical and Translational Research, Clinical / Translational Research Academy, Harvard Catalyst
Residency, 06/2015 Pediatrics, Harbor UCLA Medical Center
MD, 05/2012 Medicine, Wayne State University School of Medicine
MBS, 05/2007 Biopharmaceutical Drug Discovery and Development, Keck Graduate Institute

Publications

Karandikar MV, Milliren CE, Zaboulian R, Peiris P, Sharma T, Place AE, Sandora TJ. Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence. J Pediatric Infect Dis Soc. 2019 Oct 11.
Karandikar MV, Coffin SE, Priebe GP, Sandora TJ, Logan LK, Larsen GY, Toltzis P, Gray JE, Klompas M, Sammons JS, Harper MB, Horan K, Lakoma M, Cocoros NM, Lee GM. Variability in antimicrobial use in pediatric ventilator-associated events. Infect Control Hosp Epidemiol. 2019 01; 40(1):32-39.
Chiotos K, Tamma PD, Flett KB, Karandikar MV, Nemati K, Bilker WB, Zaoutis T, Han JH. Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children. Open Forum Infect Dis. 2018 Oct; 5(10):ofy222.
Dixit A, Karandikar MV, Jones S, Nakamura MM. Safety and Tolerability of Moxifloxacin in Children. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):e92-e101.
Chiotos K, Tamma PD, Flett KB, Naumann M, Karandikar MV, Bilker WB, Zaoutis T, Han JH. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children. Antimicrob Agents Chemother. 2017 12; 61(12).
Olszewski AE, Karandikar MV, Surana NK. Aeromonas as a Cause of Purulent Folliculitis: A Case Report and Review of the Literature. J Pediatric Infect Dis Soc. 2017 Mar 01; 6(1):e1-e3.